Bio-Rad Laboratories (BIO.B) Scheduled to Post Earnings on Tuesday

Bio-Rad Laboratories (NYSE:BIO.B) will be announcing its earnings results after the market closes on Tuesday, May 7th. Parties interested in listening to the company’s conference call can do so using this link.

Bio-Rad Laboratories (NYSE:BIO.B) last posted its earnings results on Thursday, February 15th. The company reported $3.10 earnings per share for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 23.86%. The company had revenue of $681.18 million for the quarter.

Bio-Rad Laboratories Price Performance

Shares of NYSE:BIO.B opened at $279.91 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 5.83 and a quick ratio of 4.34. The stock has a market capitalization of $7.98 billion, a P/E ratio of -13.03 and a beta of 0.70. The business has a 50-day moving average of $320.27 and a two-hundred day moving average of $314.95. Bio-Rad Laboratories has a fifty-two week low of $271.00 and a fifty-two week high of $467.95.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.